These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16632226)

  • 1. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem.
    Moncrieff J
    Med Hypotheses; 2006; 67(3):517-23. PubMed ID: 16632226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 4. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.
    Chouinard G; Chouinard VA
    Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticholinergics during neuroleptic treatment. Value and withdrawal].
    Betermiez P; Delahousse J; Pedinielli JL
    Encephale; 1986; 12(4):169-74. PubMed ID: 2878801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The risk of neuroleptic discontinuation in schizophrenia].
    Jarema M
    Psychiatr Pol; 1999; 33(1):69-81. PubMed ID: 10786216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes.
    Lambert TJ
    J Clin Psychiatry; 2007; 68 Suppl 6():10-3. PubMed ID: 17650054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of second-generation antipsychotic discontinuation in first-episode psychosis.
    Miller BJ
    J Psychiatr Pract; 2008 Sep; 14(5):289-300. PubMed ID: 18832960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between clozapine plasma levels and withdrawal symptoms].
    Berecz R; de la Rubia Martínez A; Norberto Gamero MJ; Gutiérrez Casares JR; Glaub T; Degrell I; Llerena A
    Actas Esp Psiquiatr; 2002; 30(6):397-9. PubMed ID: 12487951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-withdrawal catatonia.
    Bastiampillai T; Forooziya F; Dhillon R
    Aust N Z J Psychiatry; 2009 Mar; 43(3):283-4. PubMed ID: 19230235
    [No Abstract]   [Full Text] [Related]  

  • 15. Discontinuation of neuroleptics in community-dwelling individuals with mental retardation and mental illness.
    Pary RJ
    Am J Ment Retard; 1995 Sep; 100(2):207-12. PubMed ID: 8527116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attempting to discontinue antipsychotic medication: Withdrawal methods, relapse and success.
    Larsen-Barr M; Seymour F; Read J; Gibson K
    Psychiatry Res; 2018 Dec; 270():365-374. PubMed ID: 30300866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug withdrawal in chronic schizophrenic patients: in search of neuroleptic-induced supersensitivity psychosis.
    Weinberger DR; Bigelow LB; Klein ST; Wyatt RJ
    J Clin Psychopharmacol; 1981 May; 1(3):120-3. PubMed ID: 6117582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oculogyric crisis with exacerbation of psychosis: Possible mechanism and clinical implications.
    Thomas N; Sankar SS; Braganza D; Jayakrishnan S
    Neurosci Lett; 2009 Feb; 451(1):50-1. PubMed ID: 19121367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.